Development of a cancer pharmacopeia-wide ex-vivo drug sensitivity and resistance testing (DSRT) platform for AML: Towards individually optimized therapy and improved understanding of drug resistance patterns

: Malani D, Pemovska T, Kontro M, Murumagi A, Kulesskiy E, Yadav B, Bespalov M, Eldfors S, Elonen E, Karjalainen R, Knowles JKC, Majumder MM, Mpindi JP, Edgren H, Szwajda A, Venkata NPK, Turunen L, Mustjoki S, Wolf M, Aittokallio T, Heckman CA, Porkka K, Wennerberg K, Kallioniemi O

Publisher: AMER ASSOC CANCER RESEARCH

: 2012

: Cancer Research

: CANCER RESEARCH

: CANCER RES

: 72

: 1

: 0008-5472

DOI: https://doi.org/10.1158/1538-7445.AM2012-3188